Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 15 , ISSUE 3 ( July, 2011 ) > List of Articles


Fulminant intracranial hypertension due to cryptococcal meningitis in a child with nephrotic syndrome

Preeti Shanbag, Leena Nagotkar, Anupama Mauskar, Chaya A. Kumar

Keywords : Cryptococcal meningitis, intracranial hypertension, nephrotic syndrome

Citation Information : Shanbag P, Nagotkar L, Mauskar A, Kumar CA. Fulminant intracranial hypertension due to cryptococcal meningitis in a child with nephrotic syndrome. Indian J Crit Care Med 2011; 15 (3):176-178.

DOI: 10.4103/0972-5229.84905

License: CC BY-ND 3.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2011; The Author(s).


Cryptococcus neoformans has a worldwide distribution. Meningoencephalitis is the most common manifestation of cryptococcosis. The outcome of a patient with cryptococcal infection depends on the immune status of the host. Patients with nephrotic syndrome are particularly susceptible to cryptococcal infection not only due to innate changes in their immune system but also because of the immunosuppressive agents used in the treatment. We report an 8-year-old boy with nephrotic syndrome, who developed cryptococcal meningitis and died of fulminant intracranial hypertension.

PDF Share
  1. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000;31:499-508.
  2. Schnaper HW. The immune system in minimal change nephrotic syndrome. Pediatr Nephrol 1989;3:101-10.
  3. Qadir F, Manzoor K, Ahmed E. Disseminated cryptococcosis in a patient with nephrotic syndrome. Indian J Med Microbiol 2006;24:141-3.
  4. Nakayama M, Hori K, Ishida I, Masutani K, Katafuchi R. A case of necrotizing glomerulonephritis presenting with nephrotic syndrome associated with pulmonary cryptococcosis. Clin Exp Nephrol 2005;9:74-8.
  5. Rozenbaum R, Gonçalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994;18:369-80.
  6. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2010;50:291-322.
  7. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000;30:47-54.
  8. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91:267-72.
  9. Newton PN, Thai le H, Tip NQ, Short JM, Chierakul W, Rajanuwong A, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002;35:769-72.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.